Clinical Trial Update: A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical study comparing semaglutide injection with Wegovy for obesity management is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Semaglutide injection (semaglutide)
• WEGOVY (Semaglutide)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Obesity | Phase 3 | Status: NOT_YET_RECRUITING